The 146th Annual Meeting of the Pharmaceutical Society of Japan (Osaka)
Advanced Search

Session Details

Joint Symposium

[JS06★☆]Advancing pharmaceutical science through Kampo medicine: integrating basic research, clinical practice, and education

Fri. Mar 27, 2026 3:30 PM - 5:30 PM JST
Fri. Mar 27, 2026 6:30 AM - 8:30 AM UTC
Room 09 (B401, Bldg. 1, Area 2 [4F])
Organizer: Kimihito Tashima (Faculty Pharm. Sci., Josai International Univ.), Tomohide Akase (Grad. Sch. Business, Japan Univ. of Economics)
Co-sponsored by:
The Pharmaceutical Society of Japan,
Japan Society of Medical and Pharmaceutical Sciences for Traditional Medicine
Kampo medicine, Japanese traditional medicine, has gained significant traction in modern healthcare, with over 80% of physicians reportedly prescribing it. This rise is partly attributed to patients' increasing interest in Kampo treatments and ongoing scientific validation that provides insight into its mechanisms of action and side effects using pharmaceutical terminology. However, it is evident that many physicians do not consider the "syndrome" diagnosis based on Kampo medical theory. To address this issue, the faculty of pharmaceutical sciences has incorporated Kampo medicine into its Model Core Curriculum for Pharmaceutical Education since 2002. This initiative aims to enhance understanding and the appropriate application of Kampo medicine. It is anticipated that Kampo will continue to demonstrate therapeutic efficacy through the integration of basic and clinical research, as well as the necessary education for its effective use. This study presents recent findings on Kampo medicine, explores various perspectives, and aims to enhance its appeal within the pharmacy field.
3:30 PM - 3:35 PM JST(6:30 AM - 6:35 AM UTC)

Opening Remarks
Tomohide Akase (Grad. Sch. Business, Japan Univ, of Economics)

3:35 PM - 3:55 PM JST(6:35 AM - 6:55 AM UTC)

[JS06-1]The theoretical use of Kampo medicines (Japanese traditional medicine) based on pathophysiology and pharmacological properties

○Masamitsu Nakajima1 (1. Fac. Pharm. Sci., Hiroshima International Univ.)
3:55 PM - 4:10 PM JST(6:55 AM - 7:10 AM UTC)

[JS06-2]Current status and challenges of Japanese traditional kampo medicine (wakan-yaku) in clinical practice

○Tatsuya Nogami1, Kazushi Uneda2, Tetsuhiro Yoshino3, Hidenori Ito4, Seiya Imoto5 (1. School of Medicine, Tokai Univ., 2. Fukushima Medical Univ., 3. School of Medicine, Keio Univ., 4. Kitasato University Oriental Medicine, Kitasato Univ., 5. Institute of Medical Science, Tokyo Univ.)
4:10 PM - 4:25 PM JST(7:10 AM - 7:25 AM UTC)

[JS06-3]Issues surrounding insurance-covered kampo medicine in clinical practice

○Tomohide Akase1 (1. Japan University of Economics, Graduate School of Business)
4:25 PM - 4:40 PM JST(7:25 AM - 7:40 AM UTC)

[JS06-4]Broad spectrum anti-viral activity of Ephedrae Herba and Cinnamomi Cortex

○Shigeki Nabeshima1 (1. Fac. Medicine, Fukuoka Univ.)
4:40 PM - 4:55 PM JST(7:40 AM - 7:55 AM UTC)

[JS06-5]Goreisan in brain pharmacology: AQP4-mediated regulation of water dynamics and its therapeutic potential

○Kazuhito Murakami1 (1. Tsumura Kampo Research Laboratories)
4:55 PM - 5:10 PM JST(7:55 AM - 8:10 AM UTC)

[JS06-6]Characteristics and mechanisms of the laxative effects of rhubarb-containing Kampo medicines indicated for constipation

○Risako Kon1 (1. Hoshi Univ.)
5:10 PM - 5:25 PM JST(8:10 AM - 8:25 AM UTC)

[JS06-7]Current and future prospects of Kampo medicine

○Naoki Inagaki1 (1. Gifu U Med Sci)
5:25 PM - 5:30 PM JST(8:25 AM - 8:30 AM UTC)

Closing Remarks
Kimihito Tashima （Faculty Pharm. Sci., Josai International Univ.）

Back to Category List